Genprex, Inc.
GNPX
$0.1727
$0.00321.89%
NASDAQ
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Revenue | -- | -- | -- | -- | -- |
Total Other Revenue | -- | -- | -- | -- | -- |
Total Revenue | -- | -- | -- | -- | -- |
Cost of Revenue | -- | -- | -- | -- | -- |
Gross Profit | -- | -- | -- | -- | -- |
SG&A Expenses | 6.67M | 9.34M | 10.63M | 11.39M | 12.99M |
Depreciation & Amortization | 1.80K | 4.10K | 6.80K | 9.70K | 12.10K |
Other Operating Expenses | -- | -- | -- | -- | -- |
Total Operating Expenses | 17.31M | 19.15M | 21.17M | 22.81M | 26.27M |
Operating Income | -17.31M | -19.15M | -21.17M | -22.81M | -26.27M |
Income Before Tax | -17.56M | -19.38M | -21.39M | -22.71M | -26.14M |
Income Tax Expenses | -- | -- | -- | -- | -- |
Earnings from Continuing Operations | -17.56 | -19.38 | -21.39 | -22.71 | -26.14 |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -- | -- | -- | -- | -- |
Net Income | -17.56M | -19.38M | -21.39M | -22.71M | -26.14M |
EBIT | -17.31M | -19.15M | -21.17M | -22.81M | -26.27M |
EBITDA | -17.31M | -19.14M | -21.17M | -22.80M | -26.26M |
EPS Basic | -2.19 | -5.03 | -8.63 | -12.08 | -16.21 |
Normalized Basic EPS | -1.35 | -3.12 | -5.26 | -7.45 | -10.03 |
EPS Diluted | -2.19 | -5.03 | -8.63 | -12.08 | -16.21 |
Normalized Diluted EPS | -1.35 | -3.12 | -5.26 | -7.45 | -10.03 |
Average Basic Shares Outstanding | 55.09M | 29.66M | 16.01M | 8.77M | 6.71M |
Average Diluted Shares Outstanding | 55.09M | 29.66M | 16.01M | 8.77M | 6.71M |
Dividend Per Share | -- | -- | -- | -- | -- |
Payout Ratio | -- | -- | -- | -- | -- |